FTC demands set back DaVita's Gambro buy
This article was originally published in Clinica
Executive Summary
Ongoing discussions between DaVita and the US Federal Trade Commission over the potential antitrust implications of the former's planned acquisition of Gambro's US dialysis clinics could delay the closure of the transaction.